Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-12-01

Clinical Trial Update: Unilateral Meniere Disease: Can Double Dose Gadolinium and Delayed Imaging Make the Diagnosis? [NA]

View source ↗

Summary

This clinical trial update concerns diagnosing unilateral Meniere disease using a double-dose gadolinium MRI protocol with delayed imaging. The study has been w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gadolinium-based contrast agent (gadolinium-based contrast agent)

Snippet

Sponsor: Emory University | Conditions: Meniere Disease | NA | Status: WITHDRAWN